BGLC NASDAQ
BioNexus Gene Lab Corp.
1W: -12.2%
1M: -17.0%
3M: -41.9%
YTD: -69.0%
1Y: -77.7%
3Y: -84.9%
$1.27
+0.07 (+5.83%)
Weekly Expected Move ±9.4%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-09-25
Earliest Filing
2025-12-02
Latest Filing
partner: 9
investor: 1
Counterparties (Filed by BGLC)
10 relationshipsCompanies named in BGLC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ARC Group International Ltd. | — | investor | Agreed to purchase up to $500M of common stock over 36 months in exchange for 175,000 commitment shares. | 2025-12-02 | View |
| Fidelion Diagnostics Pte. Ltd. | — | partner | Entered into an exclusive license agreement for the VitaGuard platform and a shareholders' agreement involving equity ex | 2025-12-02 | View |
| Tongshu Biotechnology (Hong Kong) Co., Limited | — | partner | Co-signatory to the Share Subscription and Shareholders' Agreement alongside Fidelion Diagnostics Pte. Ltd. | 2025-12-02 | View |
| Maxim Group LLC | MMS | partner | Exclusive sales agent for the Company's ATM Program | 2025-11-13 | View |
| Fidelion Diagnostics Pte. Ltd. | — | partner | Strategic alliance and cross-equity partnership for VitaGuard platform commercialization in Southeast Asia | 2025-11-12 | View |
| Tongshu Biotechnology (Hong Kong) Co., Limited | — | partner | Shareholder and board appointee in the strategic alliance agreement | 2025-11-12 | View |
| Molecule Bio LLC | — | partner | Signatory to the Share Subscription and Shareholders' Agreement | 2025-11-12 | View |
| Rainy Morning Technology (Hong Kong) Limited | — | partner | Signatory to the Share Subscription and Shareholders' Agreement | 2025-11-12 | View |
| MRNA Scientific Sdn. Bhd. | — | partner | Wholly-owned subsidiary of BioNexus Gene Lab Corp. entered into a teaming agreement for biogas plant development. | 2024-09-25 | View |
| Protech Builders Sdn. Bhd. | — | partner | Malaysian mechanical and electrical engineering firm partnered with MRNA for biogas plant development. | 2024-09-25 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-28 | Other Events; Exhibits | View | |
| 2026-06-05 | Other Events; Exhibits | View | |
| 2026-03-17 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-23 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-03 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-30 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-12-23 | Other Events | View | |
| 2025-12-02 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-11-13 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-11-12 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-10-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-07-30 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-06-23 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-30 | Notice of Delisting or Transfer; Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-04-10 | Material Modification to Rights of Security Holders | View | |
| 2025-04-03 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-03-25 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-03-07 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-03-05 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-14 | Unregistered Sales of Equity Securities; Material Modification to Rights of Security Holders; Amendm | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR